[1]宋建奇,房　颖,吕　维,等.ROX指数在经鼻高流量湿化氧疗治疗Ⅰ型呼吸衰竭中的应用价值[J].新乡医学院学报,2021,38(7):671-675.[doi:10.7683/xxyxyxb.2021.07.015]
　SONG Jianqi,FANG Ying,LYU Wei,et al.Application value of ROX index in the treatment of type Ⅰ chronic respiratory failure patients with high-flow nasal cannula oxygen therapy[J].Journal of Xinxiang Medical University,2021,38(7):671-675.[doi:10.7683/xxyxyxb.2021.07.015]
点击复制

ROX指数在经鼻高流量湿化氧疗治疗Ⅰ型呼吸衰竭中的应用价值
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年7
页码:
671-675
栏目:
临床研究
出版日期:
2021-07-05

文章信息/Info

Title:
Application value of ROX index in the treatment of type Ⅰ chronic respiratory failure patients with high-flow nasal cannula oxygen therapy
作者:
宋建奇1; 房　颖1; 吕　维1; 王　娜1; 冯晓凯2; 姜纯国2; 卜小宁2
（1.北京市大兴区中西医结合医院呼吸科，北京　100076；2.首都医科大学附属北京朝阳医院呼吸与危重症医学科，北京　100076）
Author(s):
SONG Jianqi1; FANG Ying1; LYU Wei1; WANG Na1; FENG Xiaokai2; JIANG Chunguo2; BU Xiaoning2
（1.Department of Respiratory Medicine,Beijing Daxing District Integrated Traditional Chinese Medicine Hospital,Beijing 100076,China;2.Department of Respiratory and Critical Care Medicine,Beijing Chaoyang Hospital Affiliated to Capital Medical University,Beijing 100076,China）
关键词:
高流量湿化氧疗; Ⅰ型呼吸衰竭; ROX指数; 气管插管
Keywords:
high-flow nasal cannula oxygen therapy; type I chronic respiratory failure; ROX index; endotracheal intubation
分类号:
R563.1
DOI:
10.7683/xxyxyxb.2021.07.015
文献标志码:
A
摘要:
目的　探讨ROX指数在经鼻高流量湿化氧疗（HFNC）治疗Ⅰ型呼吸衰竭患者过程中对气管插管风险的预测作用。方法　选择2018 年 1 月至 2019 年 12 月北京市大兴区中西医结合医院收治的55例Ⅰ型呼吸衰竭且行HFNC治疗的患者为研究对象，根据HFNC治疗后是否接受有创正压通气分为HNFC失败组（n=19）和HFNC成功组（n=36）。采用单因素分析独立样本t 检验或χ2 检验比较2组患者年龄、性别、体质量指数（BMI）、合并症构成比、疾病严重程度［急性生理学及慢性健康状况评分Ⅱ(APACHE Ⅱ)评分、CURB-65评分、序贯器官衰竭估计 (SOFA)评分］、pH、动脉血二氧化碳分压（PaCO2）、动脉血氧分压（PaO2）以及HFNC治疗前、治疗12 h时呼吸频率、心率、氧合指数［PaO2/吸入氧体积分数（FiO2 ) ］、ROX指数。对2组间单因素分析有统计学意义的指标进一步行多因素logistic回归分析，应用受试者工作特征（ROC）曲线分析ROX 指数对HFNC治疗是否成功的预测价值。结果　HFNC治疗成功组与HFNC治疗失败组患者的性别、年龄、BMI、合并症构成比、URB65评分、SOFA评分以及治疗前 pH、PaCO2、PaO2比较差异无统计学意义（P>0.05），HFNC治疗成功组患者APACHE Ⅱ评分显著低于HFNC治疗失败组(P<0.05)，HFNC治疗前2组患者呼吸频率、心率、氧合指数、ROX指数比较差异无统计学意义（P>0.05）；HFNC治疗12 h后，HFNC治疗成功组与HFNC治疗失败组患者呼吸频率、心率比较差异无统计学意义（P>0.05），HFNC治疗成功组患者氧合指数和ROX指数显著高于HFNC治疗失败组(P<0.05)。多因素分析结果显示，HFNC治疗12 h时ROX指数为HFNC治疗是否成功的独立影响因素（OR=1.204，P<0.05），ROC曲线下面积为0.859，95%置信区间：0.746~0.927，P<0.001，截断值为5.95，敏感度为0.778，特异度为0.895。结论　HFNC治疗Ⅰ型呼吸衰竭过程中，HFNC治疗12 h时ROX指数对气管插管风险具有良好的预测作用。
Abstract:
Objective　To explore the application value of ROX index in treatment of type Ⅰ chronic respiratory failure patients whit high-flow nasal cannula oxygen therapy(HFNC).Methods　A total of 55 patients with type Ⅰ chronic respiratory failure treated with HFNC admitted to Beijing Daxing District Integrated Traditional Chinese Medicine Hospital from January 2018 to December 2019 were selected as the research subjects,they were divided into the HFNC treatment failure group(n=19) and HFNC treatment success group(n=36) according to the need of invasive positive pressure ventilation or not after HFNC.Univariate analysis was used to analyze the composition,age,gender,body mass index(BMI),constituent ratio of complications,severity of disease ［acute physiological and chronic health status Ⅱ (APACHE Ⅱ) score,CURB-65 score,sequential organ failure assessment (SOFA) score］,pH,arterial partial pressure of carbon dioxide (PaCO2),arterial partial pressure of oxygen (PaO2),and respiratory rate,heart rate,heart rate,heart rate,oxygenation index ［PaO2/fraction of inspiration O2(FiO2)］ and ROX index before and 12 hours after HFNC treatment between the two groups by independent sample t test and χ2 test.Multivariate logistic regression analysis was performed for the indexes with statistical significance in univariate analysis between the two groups,the receiver operating characteristic (ROC) curve was used to analyze the predictive value of ROX index for the risk of endotracheal intubation.Results　There was no significant difference in the gender,age,BMI,constituent ratio of complications,URB65 score,SOFA score,pH,PaCO2 and PaO2 before treatment between the two groups (P>0.05).The APACHE Ⅱ score in the HFNC treatment success group were significantly lower than those in the HFNC treatment failure group (P<0.05).There was no significant difference in respiratory rate,heart rate,oxygenation index and ROX index of patients between the two groups before HFNC treatment (P>0.05);At 12 hours of HFNC treatment,there was no significant difference in respiratory rate and heart rate of patients between the HFNC treatment success group and HFNC treatment failure group (P>0.05).The oxygenation index and ROX index of patients in the HFNC treatment success group were significantly higher than those in the HFNC treatment failure group (P<0.05).Multivariate analysis showed that the ROX index at 12 hours of HFNC treatment was an independent influencing factor for the success of HFNC treatment(OR=1.204,P<0.05),the area under the ROC curve was 0.859,95% confidence interval 0.746-0.927,P<0.001,and the cut-off value was 5.95,the sensitivity and specificity were 0.778 and 0.895,respectively.Conclusion　ROX has a good predictive value for the risk of endotracheal intubation in the treatment of type I respiratory failure with HFNC.

参考文献/References:

［1］　LI J,JING G,SCOTT J B.Year in review 2019:high-flow nasal cannula oxygen therapy for adult subjects［J］.Respir Care,2020,65(4):545-557.
［2］　中华医学会呼吸病学分会呼吸危重症医学学组,中国医师协会呼吸医师分会危重症医学工作委员会.成人经鼻高流量湿化氧疗临床规范应用专家共识［J］.中华结核和呼吸杂志,2019,42(2):83-91
［3］　RENDA T,CPRRADO A,ISKANDAR G,et al.High-flow nasal oxygen therapy in intensive care and anaesthesia［J］.Br J Anaesth,2018,120(1):18-27.
［4］　WAGSTAFF T A,SONI N.Performance of six types of oxygen delivery devices at varying respiratory rates［J］.Anaesthesia,2007,62(5):492-503.
［5］　SPICZZA L,SCHISANO M.High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure:the present and the future［J］.Ther Adv Chronic Dis,2020,11:2040622320920106.
［5］　FRAT J P,RAGOT S,GIRAULT C,et al.Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure:a post-hoc analysis of a randomised trial［J］.Lancet Respir Med,2016,4(8):646-652.
［6］　ZEMACH S,HELVIZ Y,SHITRIT M,et al.The use of high-flow nasal cannula oxygen outside the ICU［J］.Respir Care,2019,64(11):1333-1342.
［7］　KANG B J,KOH Y,LIM C M,et al.Failure of high-flow nasal cannula therapy may delay intubation and increase mortality［J］.Intensive Care Med,2015,41(4):623-632.
［8］　AGARWAL R,AGGARWAL A N,GUPTA D.Role of noninvasive ventilation in acute lung injury/acute respiratory distress syndrome:a proportion meta-analysis［J］.Respir Care,2010,55(12):1653-1660.
［9］　笪伟,何媛媛,王晓,等.ROX指数对新型冠状病毒肺炎患者经鼻高流量湿化氧疗疗效的评估价值［J］.中华急诊医学杂志,2021,30(5):588-592.
［10］　ROCA O,MESSIKA J,CARALT B,et al.Predicting success of high flow nasal cannula in pneumonia patients with hypoxemic respiratory failure:the utility of the ROX index［J］.J Crit Care,2016,35:200-205.
［11］　TOBIN M J,LAGHI F,JUBRAN A.Ventilatory failure,ventilator support,and ventilator weaning［J］.Compr Physiol,2012,2(4):2871-2921.
［12］　RICARD J D,ROCA O,LEMIALE V,et al.Use of nasal high flow oxygen during acute respiratory failure［J］.Intensive Care Med,2020,46(12):2238-2247.
［13］　王林梅.适应性支持通气在慢性阻塞性肺疾病并发呼吸衰竭老年患者撤除呼吸机过程中的应用价值［J］.新乡医学院学报,2018,35(9):810-812.
［14］　PANADERO C,ABAD-FERNNDEZ A,RIO-RAMIEZ M T,et al.High-flow nasal cannula for acute respiratory distress syndrome (ARDS) due to COVID-19［J］.Multidiscip Respir Med,2020,15(1):693.
［15］　HELVIZ Y,EINAV S.A systematic review of the high-flow nasal cannula for adult patients ［J］.Crit Care,2018,22(1):71.
［16］　LEE C U,JO Y H,LEE J H,et al.The index of oxygenation to respiratory rate as a prognostic factor for mortality in sepsis［J］.Am J Emerg Med,2020,Epub ahead of print.DOI:10.1016/j.ajem.2020.09.052.
［17］　RACA O,CARALT B,MESSIKA J,et al.An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy［J］.Am J Respir Crit Care Med,2019,199(11):1368-1376.
［18］　LEMIALE V,DUMAS G,DEMOULE A,et al.Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure［J］.Ann Intensive Care,2021,11(1):17.

更新日期/Last Update: 2021-07-05